• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体类药物治疗的类风湿关节炎中的骨转换

Bone turnover in non-steroid treated rheumatoid arthritis.

作者信息

Compston J E, Vedi S, Croucher P I, Garrahan N J, O'Sullivan M M

机构信息

Department of Rheumatology, University Hospital of Wales, Cardiff, United Kingdom.

出版信息

Ann Rheum Dis. 1994 Mar;53(3):163-6. doi: 10.1136/ard.53.3.163.

DOI:10.1136/ard.53.3.163
PMID:8154932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1005279/
Abstract

OBJECTIVE

To examine whether changes in cancellous bone turnover and resorption cavity depth contribute to bone loss in patients with non-steroid treated rheumatoid arthritis.

METHODS

Iliac crest biopsies were obtained from 37 patients with non-steroid treated rheumatoid arthritis, 13 male and 24 female, aged 37-71 years. Bone turnover and resorption cavity characteristics were quantitatively assessed using semiautomated computerised techniques.

RESULTS

When compared with age- and sex-matched control values, there was a significant reduction in bone formation rate at tissue level and activation frequency (P < 0.001) in the patient group. The eroded perimeter, mean and maximum eroded depth and cavity area were also significantly reduced (P < 0.01, < 0.005, < 0.01 and < 0.005 respectively).

CONCLUSION

These results demonstrate low bone turnover in non-steroid treated rheumatoid arthritis and indicate that the reduced bone mass in these patients is due mainly to a negative remodelling balance.

摘要

目的

研究非甾体类药物治疗的类风湿关节炎患者的松质骨转换和吸收腔深度变化是否导致骨质流失。

方法

对37例非甾体类药物治疗的类风湿关节炎患者进行髂嵴活检,其中男性13例,女性24例,年龄37 - 71岁。使用半自动计算机技术对骨转换和吸收腔特征进行定量评估。

结果

与年龄和性别匹配的对照值相比,患者组组织水平的骨形成率和激活频率显著降低(P < 0.001)。侵蚀周长、平均和最大侵蚀深度以及腔面积也显著降低(分别为P < 0.01、< 0.005、< 0.01和< 0.005)。

结论

这些结果表明非甾体类药物治疗的类风湿关节炎患者骨转换率低,提示这些患者骨量减少主要是由于负性重塑平衡所致。

相似文献

1
Bone turnover in non-steroid treated rheumatoid arthritis.非甾体类药物治疗的类风湿关节炎中的骨转换
Ann Rheum Dis. 1994 Mar;53(3):163-6. doi: 10.1136/ard.53.3.163.
2
Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.类风湿关节炎非甾体治疗患者的骨形成减少。
Ann Rheum Dis. 1989 Jun;48(6):483-7. doi: 10.1136/ard.48.6.483.
3
Systemic bone changes accompanying early rheumatoid arthritis in patients treated with nonsteroidal antiinflammatory drugs alone.仅接受非甾体抗炎药治疗的早期类风湿关节炎患者的全身骨骼变化。
Clin Orthop Relat Res. 1994 Jan(298):250-8.
4
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.英夫利昔单抗对类风湿关节炎患者骨和软骨转换标志物的长期影响。
Ann Rheum Dis. 2008 Mar;67(3):353-7. doi: 10.1136/ard.2007.076604. Epub 2007 Jul 20.
5
How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.骨转换标志物在类风湿关节炎中有多大作用?疾病活动度和皮质类固醇治疗的影响。
Rev Rhum Engl Ed. 1997 Mar;64(3):153-9.
6
Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.类风湿关节炎患者关节腔内注射糖皮质激素后,无论注射后是否休息,软骨和骨标志物的变化情况。
Ann Rheum Dis. 2005 Dec;64(12):1750-3. doi: 10.1136/ard.2004.035022. Epub 2005 Apr 20.
7
Is bone turnover a determinant of bone mass in rheumatoid arthritis?骨转换是类风湿关节炎骨量的决定因素吗?
J Rheumatol. 1998 Dec;25(12):2339-44.
8
Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.类风湿关节炎患者血清形成(PINP)和吸收(Ctx)骨转换标志物浓度。
Rheumatol Int. 2009 Oct;29(12):1403-9. doi: 10.1007/s00296-009-0867-x. Epub 2009 Feb 15.
9
Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis.非甾体类药物治疗的类风湿性关节炎患者的髂嵴小梁骨质量和结构
Ann Rheum Dis. 1987 Nov;46(11):830-6. doi: 10.1136/ard.46.11.830.
10
Does active treatment of rheumatoid arthritis limit disease-associated bone loss?类风湿关节炎的积极治疗能否限制疾病相关的骨质流失?
Rheumatology (Oxford). 2002 Sep;41(9):1047-51. doi: 10.1093/rheumatology/41.9.1047.

引用本文的文献

1
Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review.类风湿关节炎患者的骨质流失、骨质疏松症和骨折:综述
J Clin Med. 2020 Oct 20;9(10):3361. doi: 10.3390/jcm9103361.
2
Inflammation regulates fibroblast growth factor 23 production.炎症调节成纤维细胞生长因子23的产生。
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):325-32. doi: 10.1097/MNH.0000000000000232.
3
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.生物疗法治疗类风湿关节炎和强直性脊柱炎的全身骨骼效应。
Osteoporos Int. 2011 Apr;22(4):1023-36. doi: 10.1007/s00198-010-1462-4. Epub 2010 Oct 20.
4
Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot.足部糖尿病性神经病变(夏科氏)关节病中的炎性骨质溶解
Phys Ther. 2008 Nov;88(11):1399-407. doi: 10.2522/ptj.20080025. Epub 2008 Sep 18.
5
Interleukin-6 and rheumatic diseases.白细胞介素-6与风湿性疾病
Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S4. doi: 10.1186/ar1918. Epub 2006 Jul 28.
6
[Systemic manifestations of rheumatoid arthritis].[类风湿关节炎的全身表现]
Radiologe. 2006 May;46(5):403-10. doi: 10.1007/s00117-006-1360-0.
7
Dynamic exercises in patients with rheumatoid arthritis.类风湿性关节炎患者的动态锻炼
Ann Rheum Dis. 2004 Nov;63(11):1359-61. doi: 10.1136/ard.2004.020693.
8
Nitric oxide and bone.一氧化氮与骨骼
Immunology. 2001 Jul;103(3):255-61. doi: 10.1046/j.1365-2567.2001.01261.x.
9
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.类风湿关节炎和幼年类风湿关节炎中负责骨吸收的细胞类型鉴定。
Am J Pathol. 1998 Apr;152(4):943-51.

本文引用的文献

1
The early radiological signs of rheumatoid arthritis.类风湿关节炎的早期放射学征象。
Bull Rheum Dis. 1960 Nov;11:231-4.
2
Bone metabolism in rheumatoid arthritis; relation to disease activity.类风湿关节炎中的骨代谢;与疾病活动度的关系。
Br J Rheumatol. 1993 May;32(5):387-91. doi: 10.1093/rheumatology/32.5.387.
3
Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects.对正常英国受试者髂嵴骨活检的组织形态计量学分析。
Metab Bone Dis Relat Res. 1982;4(4):231-6. doi: 10.1016/0221-8747(82)90032-7.
4
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.类风湿关节炎患者的全身钙含量:疾病活动度及皮质类固醇治疗的影响
Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):330-2. doi: 10.1136/bmj.285.6338.330.
5
Incidence of metabolic bone disease in rheumatoid arthritis and osteoarthritis.类风湿关节炎和骨关节炎中代谢性骨病的发病率。
Ann Rheum Dis. 1984 Jun;43(3):370-7. doi: 10.1136/ard.43.3.370.
6
Fractures after rheumatoid arthritis. A population-based study.类风湿关节炎后的骨折。一项基于人群的研究。
Arthritis Rheum. 1984 Dec;27(12):1353-61. doi: 10.1002/art.1780271205.
7
Metabolic bone disease among in-patients with rheumatoid arthritis.
Br J Rheumatol. 1984 Nov;23(4):251-7. doi: 10.1093/rheumatology/23.4.251.
8
Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.类风湿关节炎中骨量减少的患病率。与抗炎治疗的关系。
Clin Rheumatol. 1984 Jun;3(2):201-8. doi: 10.1007/BF02030755.
9
Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids.类风湿关节炎的骨质疏松症:年龄、性别及皮质类固醇的影响
Arthritis Rheum. 1967 Oct;10(5):423-30. doi: 10.1002/art.1780100504.
10
The osteoporosis of rheumatoid arthritis.类风湿关节炎的骨质疏松症
Arthritis Rheum. 1965 Oct;8(5):943-54. doi: 10.1002/art.1780080504.